REFERENCES

• WeinshilboumR.Inheritance and drug response.N Engl J Med.200334852953712571261
   PubMed Web of Science ®Google Scholar
• LererB.MacciardiF.Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions.Int J Neuropsychopharmacol.2002525527512366879
   PubMed Web of Science ®Google Scholar
• JohnsonJA.LimaJJ.Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.Pharmacogenetics.20031352553412972951
   PubMedGoogle Scholar
• LindpaintnerK.Pharmacogenetics and pharmacogenomics in drug discovery and development: an overview.Clin Chem Lab Med.20034139841012747581
   PubMed Web of Science ®Google Scholar
• PoolsupN.Li WanPA.KnightTL.Pharmacogenetics and psychopharmacotherapy.J Clin Pharm Ther.20002519722010886465
   PubMed Web of Science ®Google Scholar
• DahlML.Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?Clin Pharmacokinet.200241770
   Web of Science ®Google Scholar
• OscarsonM.Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.Clin Chem Lab Med.20034157358012747605
   PubMed Web of Science ®Google Scholar
• CichonS.NothenMM.RietschelM.ProppingP.Pharmacogenetics of schizophrenia.Am J Med Genet2000979810610813809
   PubMed Web of Science ®Google Scholar
• GrasmaderK.VerwohltPL.RietschelM.et al.Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.Eur J Clin Pharmacol.20046032933615168101
   PubMed Web of Science ®Google Scholar
• CharlierC.BrolyF.LhermitteM.PintoE.AnsseauM.PlomteuxG.Polymorphisms in the CYP 2D6 gene: association with plasma concentrations of fluoxetine and paroxetine.Ther Drug Monit.20032573874214639062
   PubMed Web of Science ®Google Scholar
• StormerE.von MoltkeLL.ShaderRI.GreenblattDJ.Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4.Drug Metab Dispos.2000281168117510997935
   PubMed Web of Science ®Google Scholar
• YoungLT.BakishD.BeaulieuS.The neurobiology of treatment response to antidepressants and mood-stabilizing medications.J Psychiatry Neurosci.20022726026512174735
   PubMed Web of Science ®Google Scholar
• SchlossP.HennFA.New insights into the mechanisms of antidepressant therapy.Pharmacol Ther.2004102476015056498
   PubMed Web of Science ®Google Scholar
• HeilsA.TeufelA.PetriS.et al.Allelic variation of human serotonin transporter gene expression.J Neurochem.199666262126248632190
   PubMed Web of Science ®Google Scholar
• SerrettiA.LilliR.SmeraldiE.Pharmacogenetics in affective disorders.Eur J Pharmacol.20024383128
   Web of Science ®Google Scholar
• MancamaD.KerwinRW.Role of pharmacogenomics in individualising treatment with SSRls.CNS Drugs.20031714315112617694
   PubMed Web of Science ®Google Scholar
• SerrettiA.ArtioliP.Predicting response to lithium in mood disorders: role of genetic polymorphisms.Am J Pharmacogenomics.20033173012562213
   PubMedGoogle Scholar
• SiffertW.RosskopfD.SiffertG.et al.Association of a human G-protein beta3 subunit variant with hypertension [see comments].Nat Genet.19981845489425898
   PubMed Web of Science ®Google Scholar
• ZillP.BaghaïTC.ZwanzgerP.et al.Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatmentNeuroreport.2000111893189710884039
   PubMed Web of Science ®Google Scholar
• SerrettiA.LorenziC.CusinC.et al.SSRls antidepressant activity is influenced by G beta 3 variants.Eur Neuropsychopharmacol.20031311712212650956
   PubMed Web of Science ®Google Scholar
• LeeHJ.ChaJH.HamBJ.et al.Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders.Pharmacogenomics J.20044293314647404
   PubMed Web of Science ®Google Scholar
• SerrettiA.ArtioliP.From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.Psychopharmacology (Berl).200417449050314997279
   PubMed Web of Science ®Google Scholar
• DumanRS.Role of neurotrophic factors in the etiology and treatment of mood disorders.Neuromol Med.200451125
   PubMed Web of Science ®Google Scholar
• ChenB.DowlatshahiD.MacQueenGM.WangJF.YoungLT.Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.Biol Psychiatry20015026026511522260
   PubMed Web of Science ®Google Scholar
• ShimizuE.HashimotoK.OkamuraN.et al.Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.Biol Psychiatry.200354707512842310
   PubMed Web of Science ®Google Scholar
• HashimotoK.ShimizuE.lyoM.Critical role of brain-derived neurotrophic factor in mood disorders.Brain Res Brain Res Rev.20044510411415145621
   PubMedGoogle Scholar
• HolsboerF.The corticosteroid receptor hypothesis of depression.Neuropsychopharmacology.200023477501 11027914
   PubMed Web of Science ®Google Scholar
• BinderEB.SalyakinaD.LichtnerP.et al.Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.Nat Genet.2004361319132515565110
   PubMed Web of Science ®Google Scholar
• MoskowitzDW.Is angiotensin l-converting enzyme a “master” disease gene?Diabetes Technol Ther.2002468371112458570
   PubMedGoogle Scholar
• BaghaiT.SchüleC.ZwanzgerP.et al.Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders.Mol Psychiatry.2001625825911326291
   PubMed Web of Science ®Google Scholar
• BaghaiTC.SchuleC.ZwanzgerP.et al.Influence of a functional polymorphism within the angiotensin I-converting enzyme gene on partial sleep deprivation in patients with major depression.Neurosci Lett.200333922322612633893
   PubMed Web of Science ®Google Scholar
• BaghaiTC.SchuleC.ZwanzgerP.et al.Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin l-converting enzyme gene.Neurosci Lett.200232829930312147330
   PubMed Web of Science ®Google Scholar
• BondyB.BaghaiTC.ZillP.et al.Combined action of the ACE D- and the G-protein β3-allele in major depression: a possible link to cardiovascular disorder?Mol Psychiatry.200271120112612476328
   PubMed Web of Science ®Google Scholar
• KohlstedtK.BrandesRP.Muller-EsterlW.BusseR.FlemingI.Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.Circ Res.200494606714615289
   PubMed Web of Science ®Google Scholar
• GoldsteinDB.TateSK.SisodiyaSM.Pharmacogenetics goes genomic.Nat Rev Genet.2003493794714631354
   PubMed Web of Science ®Google Scholar
• LandgrebeJ.WelzlG.MetzT.et al.Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling.J Psychiatr Res.20023611912911886689
   PubMed Web of Science ®Google Scholar